Mendelian
company
About
Mendelian is helping doctors diagnose rare genetic diseases faster.
- 1 - 10
Highlights
Details
- Last Funding Type
- Non-Equity Assistant
- Industries
- Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Mendelian is helping doctors diagnose rare genetic diseases faster. Mendelian uses patient’s clinical features to find genes responsible for rare diseases. Mendelian's intelligent agent parses patient's phenotypic features entered by a physician and outputs their causative genes and mutations. Thus offering a new way of investigating undiagnosed cases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Mendelian has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2018 from a Non-Equity Assistant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2018 | Non-Equity Assistant | — | 1 |
Google for Startups
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Mendelian is funded by 1 investors.
Google for Startups
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Google for Startups
|
Yes | Non-Equity Assistant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
